Concord Biotech Delivers Strong Q1FY26 Earnings Growth
💊 CONCORDBIO reported a 43.7% year-on-year increase in consolidated net profit to ₹57.7 crore for Q1FY26. Revenue from operations rose 26.2% to ₹257.5 crore, reflecting strong business momentum and healthy operational performance.
#FundamentalViews#StockInNews
1,152 likes·69 comments